semaglutide diabetes research in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Kidney and Survival Benefits of
Description
It is an inherent consequence of how the medication works
It's why semaglutide is often prescribed in increasing dosages over a longer span of time
P., Maric I., et al
Combined research has documented additive and complementary effects on metabolic readouts measured across the trial program
